BioSpace News Archive

BioSpace Global Roundup, Nov. 7

Biotech and pharmaceutical companies from across the globe provide updates on their business and pipelines.

November 7, 2019
·
5 min read
·
Alex Keown
Business

Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer

Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that it has appointed Randall Kaye, M.D., as Chief Medical Officer (CMO)

November 7, 2019
·
2 min read
Business

Targovax ASA: Third Quarter 2019 Results

Targovax ASA, a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces its third quarter 2019 results.

November 7, 2019
·
2 min read
Drug Development

Sensorion Announces an Oral Presentation of New SENS-401 Preclinical Data at ISIET 2019 in Hannover

An oral presentation on the capacity of SENS-401 to reduce central auditory neuron loss after acoustic trauma in preclinical studies

November 7, 2019
·
5 min read
Deals

CENTOGENE Announces Pricing of Initial Public Offering at $14.00 per common share

Centogene B.V. announced the pricing of its initial public offering of 4,000,000 common shares at an initial public offering price of $14.00 per common share, for total gross proceeds of approximately $56 million.

November 7, 2019
·
3 min read
Business

Bactiguard Holding AB (publ): Interim Report for Q3 2019

The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company.

November 7, 2019
·
7 min read
Job Trends

NanOlogy Clinical Updates on Local Injection of NanoPac® for Pancreatic Cancer and Mucinous Cystic Neoplasms of the Pancreas

Interim data from both clinical trials presented at the 2019 American College of Gastroenterology (ACG) Conference in San Antonio

November 7, 2019
·
5 min read
Business

PDS Biotechnology Reports Third Quarter 2019 Financial Results and Provides Business Update

PDS Biotechnology Corporation, a clinical-stage immuno-oncology company developing multiple therapies based on T-cell activating technology called Versamune® announced its financial results for the third quarter ended September 30, 2019.

November 7, 2019
·
9 min read
Business

Dentsply Sirona Reports Third Quarter 2019 Financial Performance

DENTSPLY SIRONA Inc. announced its financial results for the three months ended September 30, 2019.

November 7, 2019
·
26 min read
Business

OsteoRemedies® Announces the Full Commercial Launch of the First Preformed Knee Spacer with Modular Stems.

OsteoRemedies®, LLC, a company focused on providing simple solutions to complex disorders, is pleased to announce the full commercial launch of the REMEDY® Stemmed Knee Spacer at the 2019 American Association of Hip and Knee Surgeons in Dallas, TX.

November 7, 2019
·
2 min read